Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$825M
-
Value change
-
-$12.9M
-
Put/Call ratio
-
1.64
-
Number of buys
-
99
-
Number of sells
-
-93
-
Price
-
$8.04
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q4 2024
313 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q4 2024.
NOVAVAX INC - Common Stock (NVAX) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 160M outstanding shares and own 64.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.7M shares), BlackRock, Inc. (13.5M shares), SHAH CAPITAL MANAGEMENT (11.1M shares), STATE STREET CORP (7.7M shares), Sanofi (6.88M shares), D. E. Shaw & Co., Inc. (5.79M shares), MORGAN STANLEY (4.94M shares), UBS Group AG (4.85M shares), GEODE CAPITAL MANAGEMENT, LLC (3.66M shares), and Deep Track Capital, LP (2M shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.